| Event title | Belgian association for cancer research |
|---|---|
| Location | Ghent |
| Period | 30 Sep 2022 → 30 Sep 2022 |
Targeting of DNMT3B in the plasma cell cancer multiple myeloma disturbs cancer cell growth and clonogenicity and boosts the anti-tumor activity of the proteasome inhibitor bortezomib
- Muylaert, Catharina (Recipient), Menu, Eline (Recipient) & De Bruyne, Elke (Recipient)
Prize: Prize (including medals and awards)